Abstract
For decades, menopausal-range women have been treated as a homogenous subgroup, with HT seen as a one-size-fits-all prescription. Hormone therapy can no longer be expected to be the automatic prescription and “cure” for female aging that clinicians only a few years ago desired it to be. Today, HT and menopause management demand a focus on managing individual symptoms, paying close attention to what the patient reports, understanding the science, and helping patients demystify the many confusing popular reports they may have heard about menopause and about hormone therapies. The menopausal-range years offer a window of therapeutic opportunity, in which clinicians can help women move from their years of reproductive potential, to the postmenopausal period, with concern for symptomatic relief and general good health.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Bechlioulis A, Naka KK, Kalantaridou SN, et al. Increased vascular inflammation in early menopausal women is associated with hot flush severity. J Clin Endocrinol Metab. 2012;97(5):E760–4.
Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J. 2007;28:2028–40.
Cumming GP, Currie HD, Panay N, et al. Stopping hormone replacement therapy: were women ill advised? Menopause Int. 2011;17:82–7.
Hisamoto K, Bender JR. Vascular cell signaling by membrane estrogen receptors. Steroids. 2005;70:382–7.
Ichikawa A, Sumino H, Ogawa T, et al. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin-aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women. Geriatr Gerontol Int. 2008;8:259–64.
Kuhl H. Mechanisms of sex steroids: future developments. Maturitas. 2004;47: 285–91.
Maki PM, Dennerstein L, Clark M. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res. 2011;1379:232–43.
Mong JA, Baker FC, Mahoney MM, et al. Sleep, rhythms, and the endocrine brain: influence of sex and gonadal hormones. J Neurosci. 2011;31(45):16107–16.
Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas. 2007;56:54–60.
Ostberg JE, Storry C, Donald AE, et al. A dose–response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol. 2007;66:557–64.
Pluchino N, Bucci F, Cela V, et al. Menopause and mental well-being: timing of symptoms and timing of hormone treatment. Womens Health (Lond Engl). 2011;7(1): 71–80.
Practice Committee of the American Society for Reproductive Medicine. Estrogen and progestogen therapy in postmenopausal women. Fertil Steril. 2008;90 suppl 3: S88–102.
Archer DF. Progestogens: effects on clinical and biochemical parameters in postmenopausal women. Menopause. 2005;12(5):484–7.
Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB. The ins and outs of GPR30: a transmembrane estrogen receptor. J Steroid Biochem Mol Biol. 2008;109(3–5): 350–3.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sherif, K. (2013). Principles of Practice. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6268-2_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6267-5
Online ISBN: 978-1-4614-6268-2
eBook Packages: MedicineMedicine (R0)